Bracco VueJect Ultrasound Contrast Delivery System Receives FDA Clearance, Health Canada Authorization

August 12, 2026—Bracco Imaging announced United States FDA 510(k) clearance and Health Canada authorization for VueJect, the company’s ultrasound contrast delivery system designed to support cardiology imaging.

SMARTFLOW Study of AngioInsight’s AngioAI+ Software Platform Begins Enrollment

August 7, 2026—AngioInsight Inc., a developer of artificial intelligence (AI)–powered cardiovascular diagnostics, announced the enrollment of the first patient in the SMARTFLOW clinical study of the company’s investigational AngioAI+ software platform.

Salus Scientific Closes Series A Financing to Support Occupational Wellness Platform

August 6, 2026—Salus Scientific Corporation announced the closing of its oversubscribed Series A financing, raising a total of $10.1 million.

ALARA+ Coalition Launches Toolkits to Accelerate Adoption of Enhanced Radiation Protection

August 6, 2026—The Society for Cardiovascular Angiography & Interventions (SCAI) and the Society of Interventional Radiology announced that the release of the ALARA+ (“As Low And As Light As Reasonably Achievable”) Coalition’s resources to help hospital leadership and decisionmakers implement enhanced radiation and occupational safety guidelines for clinicians and staff working in catheterization labs.

Caristo Diagnostics’ CaRi-Heart Coronary Inflammation Technology Receives FDA De Novo Authorization

July 30, 2026—Caristo Diagnostics announced that the FDA has granted de novo authorization for the company’s CaRi-Heart to quantify coronary inflammation from routine coronary CT angiography (CCTA).

CryoTherapeutics Commences ICECAP Trial of Localized Cryotherapy for CAD

July 27, 2026—CryoTherapeutics, based in Liège, Belgium, announced the treatment of the first patient in its ICECAP clinical trial of the company’s investigational cryotherapy system.

Egg Medical Launches EggNest Complete 2.0 Radiation Protection Device  

July 6, 2026—Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch of its next-generation EggNest Complete 2.0 system.

Arizona Enacts Law on Radiation Protection Systems for Health Care Workers

July 6, 2026—A state law addressing the safety of staff in medical procedures involving ionizing radiation, lead aprons, radiation protection systems, and real-time dosimeters was enacted by Arizona Governor Kathy Hobbs on June 19.

GE’s Allia Upgrade Pathways Introduced for Existing Interventional Suites

June 30, 2026—GE HealthCare announced the introduction of Allia platform upgrade pathways that are designed to help customers modernize select legacy Innova and Discovery image guiding solutions (IGS) systems.

Terumo’s OpusWave Dual Sensor Imaging System Introduced in the United States

June 30, 2026—Terumo Interventional Systems, a division of Terumo Corporation, announced the completion of the first United States procedure using its OpusWave dual sensor imaging system.

Abbott’s CardioMEMS Hero PA Pressure Reader Launched in United States

June 9, 2026—Abbott announced on its LinkedIn page that the company’s CardioMEMS Hero device is now available in the United States.

SCCT/SCAI Consensus Statement Standardizes Use of CT-Derived FFR

June 4, 2026—The Society of Cardiovascular Computed Tomography (SCCT) announced that, in collaboration with the Society for Cardiovascular Angiography and Interventions (SCAI), it has released an expert consensus document on the use of coronary CT angiography (CCTA)-derived fractional flow reserve (FFR-CT) for assessing coronary artery disease.

Coredio’s CPSE Platform for HF Assessment Gains FDA Breakthrough Designation

May 28, 2026—Coredio, a digital health company developing a software-as-a-medical-device platform dedicated to heart failure hemodynamic assessment, announced that the FDA has granted Breakthrough Device designation to the company’s Cardiac Performance Simulation Engine (CPSE).

Philips Introduces SmartIQ Coronary Imaging Technology for Azurion Platform in Europe

May 26, 2026—Royal Philips announced the launch of its SmartIQ coronary imaging technology for the Azurion image-guided therapy platform.

FDA Clears Acist Pro Diagnostic System

May 18, 2026—Acist Medical Systems, Inc., a Bracco company, announced FDA clearance and the United States launch of the Acist Pro diagnostic system, which is a next-generation variable-rate contrast management solution for image-guided cardiovascular procedures.

Abbott’s Ultreon 3.0 AI Coronary Imaging Platform Receives FDA Clearance, CE Mark Approval

May 1, 2026—Abbott announced it received FDA clearance and CE Mark approval for its next-generation Ultreon 3.0 software, an artificial intelligence (AI)–powered imaging platform that uses optical coherence tomography (OCT) to provide real-time planning guidance during percutaneous coronary intervention (PCI) procedures.

Conavi’s IVUS-OCT System for Intravascular Imaging Cleared by FDA

April 21, 2026—Conavi Medical Corp., a developer of imaging technologies to guide common minimally invasive cardiovascular procedures, announced that it has received FDA 510(k) clearance for its next-generation hybrid imaging system.

Elucid Introduces Lesion Inspection Tool for Plaque-IQ Software Suite

April 20, 2026—Elucid announced the commercial availability of a new lesion inspection tool for coronary and carotid plaque analysis in its Plaque-IQ software suite.

Medtronic Completes Acquisition of CathWorks

April 20, 2026—Medtronic announced it has completed its acquisition of CathWorks, a privately held medical device company focused on the diagnosis and treatment of coronary artery disease with its fractional flow reserve (FFR) diagnostic technology.

Egg Medical Launches EggNest Complete Flex for Apron-Free Radiation Protection

April 9, 2026—Egg Medical announced the launch of EggNest Complete Flex radiation protection, which enables clinicians to safely work apron-free or with ultralight lead aprons.